Sector : Pharmaceuticals
BSE
240.40 1.16%
NSE
240.65 1.2 %
Oct 17, 11:02
Initiate long positions in auto, banks, metal stocks; IndusInd Bank ripe for bounce back
Oct 14, 16:01
Cadila Healthcare Q2 PAT may dip 23% YoY to Rs. 321.5 cr: Emkay
Oct 09, 14:12
Cadila Healthcare gains 4% on USFDA approval for cholesterol-lowering drug
Sep 30, 21:48
Cadila inks pact to sell rights of cholesterol lowering drug in US, Canada to Medicure
Oct 18, 16:00
Price
BSE
240.40 1.16%
NSE
240.65 1.2%
Share Target
Target(Rs)
Tip Period
Stop Loss
Your permanent Nickname can be distinct from your username and no one need know the link between the two.
Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.
